2020 ASCO Virtual Direct™ Highlights


 

2020 ASCO Updates on HPV+ Oropharynx Cancer: Can TORS and Reduced Dose Post-Operative RT Maintain High Cure Rates and Decrease Late Toxicity in Intermediate Risk Disease?

11 views
September 29, 2020
Comments 0
Login to view comments. Click here to Login